Lectin-Conjugated Liposomes as Biocompatible, Bioadhesive Drug Carriers for the Management of Oral Ulcerative Lesions-Reference-Cited by-同舟云学术

Lectin-Conjugated Liposomes as Biocompatible, Bioadhesive Drug Carriers for the Management of Oral Ulcerative Lesions

Published:2018-09-22 Issue:5 Volume:1 Page:1487-1495
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

Wijetunge Sashini S.¹,Wen Jianchuan¹^ORCID,Yeh Chih-Ko²,Sun Yuyu¹^ORCID

Affiliation:

1. Department of Chemistry, University of Massachusetts Lowell, 1 University Avenue, Lowell, Massachusetts 01854, United States of America

2. Department of Comprehensive Dentistry, University of Texas Health Science Center at San Antonio and Geriatric Research Education and Clinical Center, Audie L. Murphy Division, South Texas Veterans Health Care System, 7400 Merton Minter Boulevard, San Antonio, Texas 78229, United States of America

Publisher

American Chemical Society (ACS)

Subject

Biochemistry, medical,Biomedical Engineering,General Chemistry,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.8b00425

Reference43 articles.

1. Ulcerative Lesions of the Oral Cavity

2. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies

3. Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients

4. Management of oral mucositis in patients with cancer

5. Oral ulcers in HIV-infected patients: An update on epidemiology and diagnosis

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Plant Lectins in the Cellular and Molecular Processes of Skin Wound Repair: An Overview;Current Pharmaceutical Design;2023-09

2. Formulation and Evaluation of Chitosan-PLGA Biocomposite Scaffolds Incorporated with Quercetin Liposomes Made by QbD Approach for Improved Healing of Oral Lesions;AAPS PharmSciTech;2023-06-28

3. Mucoadhesive drug delivery systems: a promising non-invasive approach to bioavailability enhancement. Part I: biophysical considerations;Expert Opinion on Drug Delivery;2023-02-21

4. Studies on the drug delivery utilizing glycan-protein interactions;Drug Delivery System;2023

5. A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death;Journal of Translational Medicine;2022-12-09